Facebook
  1. Home
  2. Solutions
  3. Laboratories
  4. Bioanalytical Laboratories
  5. Liquid Scintillation Counting (LSC)

Liquid Scintillation Counting (LSC)

High-sensitivity radioactivity detection

ICON offers advanced Liquid Scintillation Counting (LSC) capabilities to support sponsors in generating accurate, reliable radioactivity data from clinical trial samples.

This powerful technique enables precise quantification of low-energy beta and alpha-emitting isotopes across a wide range of biological matrices—including blood, plasma, urine, feces, bile, and exhaled air.

LSC delivers:

Data

Accelerated data turnaround

With multiple LSC instruments on-site and close proximity to ICON’s early phase clinical research unit in Groningen, we ensure fast, efficient sample processing and data delivery—minimising delays and keeping your study on track.

Labs

Validated methods for complex samples

ICON uses rigorously validated protocols and dedicated equipment to process challenging sample types, ensuring high reproducibility and regulatory-grade data.

International research network

Support for global trials

Whether your samples originate from ICON’s European clinics or global trial sites, our infrastructure is designed to handle international logistics and maintain sample integrity throughout the process.

Lab_Equipment

Specialised techniques for ADME studies

Our lab performs advanced procedures such as feces homogenization and combustion to analyse radiolabeled carbon dioxide (¹⁴CO₂)—a critical metric for calculating drug-related excretion balance in human ADME trials.

Regulatory_Documents

Regulatory confidence

ICON’s bioanalytical workflows are built to meet global regulatory standards, giving sponsors confidence in the quality and compliance of their data for submission.

Partner with ICON

Streamline your radiolabelled studies, reduce risk, and generate high-quality data that drives confident decision-making throughout drug development.

Contact us
In this section

Connect with us